Clincosm LogoSign in Get a demo

CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium

Sponsor
European Pathway Association (Other)
Overall Status
Completed
CT.gov ID
NCT02030210
Collaborator
Universitaire Ziekenhuizen Leuven (Other), KU Leuven (Other)
32
Enrollment
1
Location
4
Duration (Months)
7.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

RAND/UCLA modified Delphi study on quality indicators for STEMI to determine the appropriateness of quality indicators retrieved from literature and guideline review. We aim to engage 20 cardiologists and 20 nurses with relevant experience in the care for STEMI patients.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    32 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Quality of Care for STEMI - Patients. a Research to Determine Appropriateness of STEMI Quality Indicators in Belgium, a RAND/UCLA Modified Delphi Study
    Study Start Date :
    Jul 1, 2013
    Actual Primary Completion Date :
    Nov 1, 2013
    Actual Study Completion Date :
    Nov 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    cardiologists
    study coordinators
    registred nurses

    Outcome Measures

    Primary Outcome Measures

    1. validated quality indicators for STEMI care in belgium (both on patient and on hospital level) [2 months]

      33 experts in cardioloy, cardio nursing and quality rated quality indicators for STEMI care in belgian hospitals on a 9 point Likert Scale. All indicators with a median score between 7 and 9 were discussed in an expert panel. The expert panel selected validated quality inidicators for STEMI care.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • cardiologist or cardio nurse with relevant experience in the care for STEMI patients
    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 KU Leuven Leuven Vlaams Brabant Belgium

    Sponsors and Collaborators

    • European Pathway Association
    • Universitaire Ziekenhuizen Leuven
    • KU Leuven

    Investigators

    • Principal Investigator: Kris Vanhaecht, dr, KU Leuven

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Kris Vanhaecht, Study director, European Pathway Association
    ClinicalTrials.gov Identifier:
    NCT02030210
    Other Study ID Numbers:
    • CP4ACS\2013\1
    First Posted:
    Jan 8, 2014
    Last Update Posted:
    Apr 4, 2022
    Last Verified:
    Mar 1, 2022
    Keywords provided by Dr. Kris Vanhaecht, Study director, European Pathway Association
    Quality improvement
    STEMI
    Belgium
    Additional relevant MeSH terms:
    ST Elevation Myocardial Infarction

    Study Results

    No Results Posted as of Apr 4, 2022